Astrocytes target white matter stroke and other neurodegenerative diseases
Medical Xpress - 12-Aug-2021Reliable and safe generation of a novel stem cell-based therapy for dementia
Join the club for FREE to access the whole archive and other member benefits.
Neurologist and neuroscientist in the Departments of Neurology and of Neurobiology at the David Geffen School of Medicine at UCLA
Neurologist and neuroscientist in the Departments of Neurology and of Neurobiology at the David Geffen School of Medicine at UCLA. He has active laboratory and clinical interests in stroke and neurorehabilitation and how the brain repairs from injury. He received his M.D. and Ph.D. degrees from Washington University School of Medicine in 1993 and 1994, and completed a Neurology residency at Washington University School of Medicine, serving as Chief Resident. Dr. Carmichael was a Howard Hughes Medical Institute postdoctoral fellow at UCLA from 1998-2001. He has been on the UCLA faculty since 2001. His laboratory studies include molecular and cellular mechanisms of neural repair after stroke and other forms of brain injury.
Visit website: https://bioscience.ucla.edu/people/s-thomas-carmichael-jr/
See also: David Geffen School of Medicine at UCLA - Accredited medical school at UCLA.
Details last updated 14-Aug-2021
Reliable and safe generation of a novel stem cell-based therapy for dementia